IL148185A0 - Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction - Google Patents
Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstructionInfo
- Publication number
- IL148185A0 IL148185A0 IL14818500A IL14818500A IL148185A0 IL 148185 A0 IL148185 A0 IL 148185A0 IL 14818500 A IL14818500 A IL 14818500A IL 14818500 A IL14818500 A IL 14818500A IL 148185 A0 IL148185 A0 IL 148185A0
- Authority
- IL
- Israel
- Prior art keywords
- fallopian tube
- pelvic pain
- chronic pelvic
- endometrial tissue
- therapeutic management
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15547899P | 1999-09-23 | 1999-09-23 | |
PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148185A0 true IL148185A0 (en) | 2002-09-12 |
Family
ID=22555601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14818500A IL148185A0 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1214086A2 (en) |
JP (2) | JP2003509467A (en) |
KR (1) | KR100772852B1 (en) |
CN (2) | CN1376070A (en) |
AU (1) | AU769482B2 (en) |
BG (1) | BG66128B1 (en) |
BR (1) | BR0014198A (en) |
CA (1) | CA2383510A1 (en) |
HK (1) | HK1049117A1 (en) |
HU (1) | HUP0202741A3 (en) |
IL (1) | IL148185A0 (en) |
MX (1) | MXPA02002436A (en) |
NO (1) | NO331198B1 (en) |
NZ (1) | NZ534836A (en) |
PL (1) | PL201898B1 (en) |
RU (1) | RU2255759C2 (en) |
SK (1) | SK3752002A3 (en) |
TR (1) | TR200200738T2 (en) |
TW (1) | TWI267373B (en) |
UA (1) | UA73956C2 (en) |
WO (1) | WO2001021194A2 (en) |
ZA (1) | ZA200201374B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10157628A1 (en) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Solution for injection of an LHRH antagonist |
US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
KR101749310B1 (en) | 2008-01-24 | 2017-06-21 | 에스퍼란스 파마슈티컬스, 인코포레이티드 | Lytic domain fusion constructs and methods of making and using same |
CA2750582A1 (en) * | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
DK2914633T3 (en) | 2012-10-30 | 2022-03-14 | Esperance Pharmaceuticals Inc | ANTIBODY / MEDICINAL CONJUGATES AND METHODS OF USE |
JP6159870B2 (en) | 2013-03-15 | 2017-07-05 | アッヴィ・インコーポレイテッド | Composition for use in the treatment of hypermenstrual bleeding and uterine fibroids |
CN112261942A (en) | 2018-04-19 | 2021-01-22 | 艾伯维公司 | Method for treating severe menstrual bleeding |
EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
SE9301606D0 (en) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH |
CN1137722C (en) * | 1994-07-22 | 2004-02-11 | 汉普顿路医学院 | Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
DE19513662A1 (en) * | 1995-04-08 | 1996-10-10 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
DE19604231A1 (en) * | 1996-01-29 | 1997-07-31 | Schering Ag | Combined pharmaceutical preparation and its use for the treatment of gynecological disorders |
CN1228708A (en) * | 1996-09-04 | 1999-09-15 | 有限会社多特 | Peptide-containing drug compositions for oral administration |
CA2292605A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
DE19911771B4 (en) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH antagonist, process for its preparation and its use |
-
2000
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/en active IP Right Grant
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/en not_active Application Discontinuation
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/en not_active IP Right Cessation
- 2000-09-20 PL PL353244A patent/PL201898B1/en not_active IP Right Cessation
- 2000-09-20 CN CN00813196A patent/CN1376070A/en active Pending
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/en not_active Withdrawn
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/en not_active Application Discontinuation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/en unknown
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/en not_active IP Right Cessation
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/en active Pending
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/en unknown
- 2000-09-20 UA UA2002043346A patent/UA73956C2/en unknown
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 IL IL14818500A patent/IL148185A0/en not_active IP Right Cessation
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-22 TW TW089119671A patent/TWI267373B/en not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/en not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/en unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/en unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2255759C2 (en) | 2005-07-10 |
SK3752002A3 (en) | 2003-06-03 |
NO20021430L (en) | 2002-05-07 |
AU769482B2 (en) | 2004-01-29 |
HUP0202741A2 (en) | 2003-01-28 |
TR200200738T2 (en) | 2002-08-21 |
NZ534836A (en) | 2007-07-27 |
MXPA02002436A (en) | 2003-02-12 |
JP2012051920A (en) | 2012-03-15 |
BG66128B1 (en) | 2011-06-30 |
BG106584A (en) | 2003-02-28 |
JP2003509467A (en) | 2003-03-11 |
TWI267373B (en) | 2006-12-01 |
KR20020035879A (en) | 2002-05-15 |
NO20021430D0 (en) | 2002-03-21 |
HK1049117A1 (en) | 2003-05-02 |
BR0014198A (en) | 2002-05-21 |
PL353244A1 (en) | 2003-11-03 |
HUP0202741A3 (en) | 2003-12-29 |
CN101045155A (en) | 2007-10-03 |
UA73956C2 (en) | 2005-10-17 |
EP1214086A2 (en) | 2002-06-19 |
AU7779200A (en) | 2001-04-24 |
KR100772852B1 (en) | 2007-11-02 |
NO331198B1 (en) | 2011-10-31 |
PL201898B1 (en) | 2009-05-29 |
WO2001021194A2 (en) | 2001-03-29 |
CN1376070A (en) | 2002-10-23 |
WO2001021194A3 (en) | 2002-03-14 |
ZA200201374B (en) | 2002-10-30 |
CA2383510A1 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3734300A (en) | Method and apparatus for establishing and maintaining therapeutic hypothermia | |
IL132760A0 (en) | Vibrator for treatment of constipation | |
AU3968401A (en) | System for warming lower extremities of supine persons | |
AU7842500A (en) | System for orthopedic treatment | |
EP1404343A4 (en) | Therapeutic combinations for the treatment of hormone deficiencies | |
AU1227302A (en) | System and method for optimizing drug therapy for the treatment of diseases | |
MY145215A (en) | Vaginalli administered anti-dysrhythmic agents for treating uterine dysrhythmia | |
AU2317600A (en) | Pressure-pulse therapy apparatus for treatment of tissue | |
IL148185A0 (en) | Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction | |
IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
HUP0204448A3 (en) | Trnasdermal therapeutic system for the delivery of lerisetron | |
HK1048441A1 (en) | Drug for treating fractures | |
HK1047687A1 (en) | Device for coagulation of tissues | |
GB2370507B (en) | Apparatus for the diagnosis and therapy of neuro-muscular and other tissue disorders | |
EP1171579A4 (en) | Human tumor necrosis factor receptor tr9 | |
EP1210370A4 (en) | Human tumor necrosis factor receptor tr16 | |
HUP0402664A3 (en) | 2-indanylamino derivatives for the therapy of chronic pain | |
GB9911238D0 (en) | Therapeutic use | |
TW422099U (en) | Spinal massage device | |
PL351081A1 (en) | Treatment of hiatial hernia | |
GB9912184D0 (en) | Therapeutic use | |
GB9924980D0 (en) | Therapeutic treatment | |
GB9901505D0 (en) | Therapeutic treatment | |
GB9826888D0 (en) | Cervical cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |